Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci192599 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Fanen Yuan und 16 weiteren Autor:innen. Beteiligte Einrichtung: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Glioblastoma, Copper, Neoplastic Stem Cells, Circadian Rhythm. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Cuproptosis involves accumulation of intracellular copper that triggers mitochondrial lipoylated protein aggregation and destabilization of iron–sulfur cluster proteins, leading to cell death. Pharmacologic induction of cuproptosis has been proposed as a cancer therapy. Here, we find that glioblastoma (GBM) stem cells (GSCs) displayed relative resistance to cuproptosis with circadian variation of intracellular copper levels. CRISPR screening of copper regulators under concurrent treatment with copper ionophore or clock disruption revealed dependency on ATPase copper transporting alpha ( ATP7A ). Circadian control of copper homeostasis was mediated by the core clock transcription factor, brain and muscle ARNT-like 1 ( BMAL1 ). In turn, ATP7A promoted tumor cell growth through regulation of fatty acid desaturation. Copper levels negatively fed back into the circadian circuitry through sequestosome 1/p62–mediated lysosomal degradation of BMAL1. Targeting the circadian clock or fatty acid desaturation augmented cuproptosis antitumor effects. Crosstalk between the core circadian clock and copper sustains GSCs, reshaping fatty acid metabolism and promoting drug resistance, which may inform development of combination therapies for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA.
- Department of Neurosurgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
- Department of Medicine and.
- Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Förderung
- NCI NIH HHS
- NINDS NIH HHS
- National Cancer Institute
- National Institute of Neurological Disorders and Stroke
- Defense Health Agency
Zitieren
APA
Yuan, F., Wu, X., Yuan, H., Wang, D., Huang, T., Zhang, P., Mi, H., Wu, W., Taori, S., Chan, P., Miki, K., Ghoche, M. T., Zhao, L., Abdullah, K. G., Kay, S. A., Wu, Q., & Rich, J. N. (2026). Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels. Journal of Clinical Investigation. https://doi.org/10.1172/jci192599
Vancouver
Yuan F, Wu X, Yuan H, Wang D, Huang T, Zhang P, et al. Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels. Journal of Clinical Investigation. 2026. doi:10.1172/jci192599
BibTeX
@article{Yuan2026,
author = {Yuan, Fanen and Wu, Xujia and Yuan, Huairui and Wang, Donghai and Huang, Tengfei and Zhang, Po and Mi, Hailong and Wu, Weichi and Taori, Suchet and Chan, Priscilla and Miki, Kenji and Ghoche, Maged T and Zhao, Linjie and Abdullah, Kalil G and Kay, Steve A and Wu, Qiulian and Rich, Jeremy N},
title = {Glioblastoma stem cells resist cuproptosis with circadian variation of copper levels},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci192599}
}
EUVIMED